A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

被引：0
|
作者：
Patrizia Vici
Giuseppe Colucci
Francesco Giotta
Domenico Sergi
Gianfranco Filippelli
Pasquale Perri
Claudio Botti
Enrico Vizza
Armando Carpino
Laura Pizzuti
Agnese Latorre
Diana Giannarelli
Massimo Lopez
Luigi Di Lauro
机构：
[1] Regina Elena National Cancer Institute,Division of Medical Oncology B
[2] Oncologic Institute,Department of Medical and Experimental Oncology
[3] Division of Medical Oncology,Division of Surgery A
[4] S. Francesco Hospital,Division of Gynecological Oncology
[5] Regina Elena National Cancer Institute,Cardiologic Unit
[6] Regina Elena National Cancer Institute,Biostatistics Unit
[7] Regina Elena National Cancer Institute,undefined
[8] Regina Elena National Cancer Institute,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词：
Anthracyclines; Lapatinib; Pegylated Liposomal Doxorubicin; Neutropenic Fever; Advanced Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer
    Keller, AM
    Mennel, R
    Georgoulias, VA
    Nabholtz, JM
    Erazo, A
    Lluch, A
    Vogel, CL
    Kaufmann, M
    von Minckwitz, G
    Henderson, IC
    Mellars, L
    Alland, L
    Tendler, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3893 - 3901
  • [32] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Liang Huang
    Xiaojia Wang
    Liheng Zhou
    Lijun Di
    Hongyu Zheng
    Zefei Jiang
    Yongsheng Wang
    Xiangqun Song
    Jifeng Feng
    Shiying Yu
    Yunpeng Liu
    Hong Zheng
    Kunwei Shen
    Zhongsheng Tong
    Zhimin Shao
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 205 - 215
  • [33] Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
    Huang, Liang
    Wang, Xiaojia
    Zhou, Liheng
    Di, Lijun
    Zheng, Hongyu
    Jiang, Zefei
    Wang, Yongsheng
    Song, Xiangqun
    Feng, Jifeng
    Yu, Shiying
    Liu, Yunpeng
    Zheng, Hong
    Shen, Kunwei
    Tong, Zhongsheng
    Shao, Zhimin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 205 - 215
  • [34] Epirubicin (EPI) and vinorelbine (VNB) as first-line chemotherapy (fICT) in advanced breast cancer (ABC). (GOIM Gruppo Oncologico Italia Meridionale).
    Vici, P
    Colucci, G
    Gebbia, V
    Giotta, F
    Amodio, A
    Gebbia, N
    Pezzella, G
    Belli, F
    Durini, E
    Lopez, M
    ANNALS OF ONCOLOGY, 2000, 11 : 33 - 33
  • [35] A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)
    Palumbo, Raffaella
    Bernardo, Antonio
    Strada, Maria Rosa
    Poggi, Guido
    Delmonte, Angelo
    Teragni, Cristina
    Frascaroli, Mara
    Bernardo, Giovanni
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [36] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [37] Phase II randomized trial of pegylated liposomal doxorubicin vs. weekly docetaxel with subsequent crossover as first-line chemotherapy for metastatic breast cancer.
    Yardley, DA
    Shipley, DM
    Greco, FA
    Montes, I
    McCarthy, M
    Hainsworth, JD
    Burris, HA
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S204
  • [38] Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial
    Del Barco, S.
    Colomer, R.
    Calvo, L.
    Tusquets, I.
    Adrover, E.
    Sanchez, P.
    Rifa, J.
    De la Haba, J.
    Virizuela, J. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (02) : 351 - 358
  • [39] Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial
    S. Del Barco
    R. Colomer
    L. Calvo
    I. Tusquets
    E. Adrover
    P. Sánchez
    J. Rifà
    J. De la Haba
    J. A. Virizuela
    Breast Cancer Research and Treatment, 2009, 116 : 351 - 358
  • [40] Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 699 - 703
12345